Both men and women should understand cervical cancer

Share This Post

Although more than 12,000 women in the United States are diagnosed with cervical cancer every year and about 4,000 people die of cervical cancer, cervical cancer can be prevented through regular inspections. If it is discovered and treated early, it can be cured. Almost all cervical cancers are caused by an HPV (human papilloma virus), an infection that can be passed from one person to another during sexual activity.

It is estimated that about 79 million Americans have HPV, and many people do not know that they are infected with HPV. Most HPV patients will not experience symptoms. In most cases, the infection disappears on its own. Otherwise, it will cause a variety of cancers in men and women, including cervical cancer, vulvar cancer, vaginal cancer, anal cancer, laryngeal cancer, tongue cancer, tonsil cancer and penile cancer.

Fortunately, we have HPV-type vaccines that cause most cervical cancer and genital warts. The US Centers for Disease Control and Prevention recommends that young girls and boys be vaccinated against HPV when they are 11 or 12 years old, but women under 26 and men under 21 can still be vaccinated. Those college students who have not been vaccinated do so regardless of gender.

Preventing HPV can help prevent cervical cancer. The best way to prevent HPV is through vaccination, safe sex, restricting the number of partners, and not smoking.

Pap test (or cervical smear) helps to find pre-cancerous lesions, the only way for cervical cells to change. If not handled properly, it may become cervical cancerHPV testing can detect viruses that cause changes in these cells. Both tests can be performed by a doctor at the same time. Women should start regular Pap tests at the age of 21 , and women aged 30 and over are recommended to undergo joint Pap tests / HPV.

 Tips: At present, only two-valent and four-valent vaccines are listed on the mainland, which protects up to four viruses. Hong Kong has already listed nine-valent vaccines to prevent nine virus infections. Global Oncologist Network can help you inject nine-valent vaccines. Full protection!

https://m.medicalxpress.com/news/2018-01-facts-women-men-cervical-cancer.html

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Claudin18.2-targeted CAR-T cell therapy brings complete remission in advanced pancreatic cancer patient A case report
CAR T-Cell therapy

Claudin18.2-targeted CAR-T cell therapy brings complete remission in advanced pancreatic cancer patient : A case report

Claudin18.2-targeted CAR-T cell therapy has shown remarkable potential in treating advanced pancreatic cancer, as highlighted in a recent case report. This innovative approach led to complete remission in a patient with advanced disease, underscoring the promise of targeted immunotherapy. By leveraging the specific expression of Claudin18.2 on cancer cells, this therapy offers a precision-based treatment, heralding a new era in pancreatic cancer management with significant clinical implications.

What is the treatment after BCMA CAR T failed in RR multiple myeloma cases
CAR T-Cell therapy

What is the treatment after BCMA CAR T failed in R/R multiple myeloma cases?

For people with relapsed or refractory multiple myeloma, BCMA CAR T-cell therapy might not work. Other treatments, such as bispecific antibodies, other CAR T-cell therapies that target different antigens, and combination regimens with immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies, can still be used. OriCAR-017 is another immunotherapy that is under trial and is expected to be launched soon. Clinical trials offer experimental treatments, providing access to novel therapies. Tailored approaches based on patient-specific factors and emerging research are crucial for improving outcomes in this challenging scenario.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy